NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE:BBWI).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those […]
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ:POM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Snowflake Inc. ("Snowflake" or the "Company") (NYSE:SNOW).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ:RR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against monday.com Ltd. ("monday" or the "Company") (NYSE:MNDY).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803,
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Camping World Holdings, Inc. ("Camping World" or the "Company") (NYSE:CWH).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. ("uniQure" or the "Company") (NASDAQ:QURE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged